NCT02792972

Brief Summary

Context: Research on natural products with therapeutic, analgesic or antimicrobial purpose should be encouraged to create new drugs. Acmella oleracea, typical plant of the Northern region of the country and popularly known as jambu, has aroused the interest of researchers because of its therapeutic potential. Objective: To evaluate the potential topical analgesic and antimicrobial of Acmella oleracea plant extract from the skin antisepsis in venipuncture procedures. Methods: This is a clinical, randomized, controlled trial with healthy volunteers recruited at the Clinic I of the collection of biological materials sector of the Hospital das Clinicas Samuel Libânio, in Pouso Alegre-MG. The plant extract A. oleracea manipulated with Transcutol® and 70% alcohol were used in the volunteers before the venipuncture procedure as allocation in study groups. Held collection of skin microbiota by the swab technique and the end of the venipuncture procedure was applied to the volunteer, the visual numeric scale (VNS) standard to determine the degree of pain.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 8, 2016

Completed
Last Updated

June 8, 2016

Status Verified

June 1, 2016

Enrollment Period

Same day

First QC Date

May 23, 2016

Last Update Submit

June 7, 2016

Conditions

Keywords

AnalgesicMedicinal plantsSkinAntimicrobial agentsPain Measurement

Outcome Measures

Primary Outcomes (2)

  • The degree of pain in 15 healthy volunteers will be measured by the visual numeric scale (VNS) standard immediately after the venipuncture procedure.

    1 day

  • The skin microflora in 15 healthy volunteers will be measured counted the microorganism isolated by swab technique and plated on plates containing the medium Standard Methods Agar (PCA).

    1 day

Study Arms (2)

Acmella oleracea

ACTIVE COMPARATOR

The plant extract A. oleracea manipulated with Transcutol® were used in the volunteers 3 minutes before the venipuncture

Other: A. oleracea

alcohol 70%

PLACEBO COMPARATOR

70% alcohol were used in the volunteers 3 minutes before the venipuncture

Other: 70% alcohol

Interventions

The plant extract A. oleracea manipulated with Transcutol® were used in the volunteers before the venipuncture procedure as allocation in study groups. Held collection of skin microbiota by the swab technique and the end of the venipuncture procedure was applied to the volunteer, the visual numeric scale (VNS) standard to determine the degree of pain.

Also known as: medical plants
Acmella oleracea

70% alcohol were used in the volunteers before the venipuncture procedure as allocation in study groups. Held collection of skin microbiota by the swab technique and the end of the venipuncture procedure was applied to the volunteer, the visual numeric scale (VNS) standard to determine the degree of pain.

alcohol 70%

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy volunteers
  • without restriction as to ethnicity
  • educational level and social class who agreed to participate by signing the Informed Consent and Informed (IC )

You may not qualify if:

  • pregnant women (due to contractile properties that can cause )
  • cancer patients
  • chronic and refusal to participate in the study kidney

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Ethanol

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Ana Beatriz A Teixeira Loyola, doctor

    Universidade do Vale do Sapucaí

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 23, 2016

First Posted

June 8, 2016

Study Start

September 1, 2015

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

June 8, 2016

Record last verified: 2016-06